SK Holdings (034730 KS) aims to raise US$1bn via selling 11% of SK Biopharmaceuticals Co Ltd (326030 KS). The shares have more than tripled since listing and the IPO lock-up just expired last month.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.